3-122610643-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001113523.3(PARP15):āc.456C>Gā(p.Phe152Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,551,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001113523.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARP15 | NM_001113523.3 | c.456C>G | p.Phe152Leu | missense_variant | 3/12 | ENST00000464300.7 | NP_001106995.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARP15 | ENST00000464300.7 | c.456C>G | p.Phe152Leu | missense_variant | 3/12 | 1 | NM_001113523.3 | ENSP00000417214.2 | ||
PARP15 | ENST00000483793.5 | c.456C>G | p.Phe152Leu | missense_variant | 3/9 | 1 | ENSP00000417785.1 | |||
PARP15 | ENST00000465304.5 | n.432C>G | non_coding_transcript_exon_variant | 4/14 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000639 AC: 1AN: 156528Hom.: 0 AF XY: 0.0000121 AC XY: 1AN XY: 82870
GnomAD4 exome AF: 0.0000136 AC: 19AN: 1399232Hom.: 0 Cov.: 30 AF XY: 0.0000159 AC XY: 11AN XY: 690126
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74338
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at